Analysis and Prediction of Absorption Behavior for Theophylline Orally Administered as Powders Based on Gastrointestinal-transit-Absorption (Gita) Model

Drug Metabolism and Pharmacokinetics

Volumn 17, Issue 4, 2002, Pages 307-315

  Kadono, Keitaro ^a   Yokoe, Jun ichi ^a   Ogawara, Ken ichi ^a   Higaki, Kazutaka ^a   Kimura, Toshikiro ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

biopharmaceutics classi cation system class I; gastrointestinal transit absorption (GITA) model; oral absorption; powder; prediction; theophylline

Indexed keywords

EID: 84982814204     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.17.307     Document Type: Article

References (30)

1. Clements, J. A., Heading, R. C., Nimmo, W. S. and Prescott, L. F.: Kinetics of acetaminophen absorption and gastric emptying in man. Clin. Pharmacol. Ther., 24: 420-431 (1978).
2. Haruta, S., Iwasaki, N., Ogawara, K., Higaki, K. and Kimura, T.: Absorption behavior of orally administered drugs in rats treated with propantheline. J. Pharm. Sci., 87: 1081-1085 (1998).
3. Patel, V. S. and Kramer, W. G.: Allopurinol absorption from diŝerent sites of the rat gastrointestinal tract. J. Pharm. Sci., 75: 275-277 (1986).
4. Tukker, J. J. and Poelma, F. G. J.: Site-dependent absorption in the rat intestine. Abstract, Third Int. Conf. on Drug Absorption, Edinburgh, p. 45 (1988).
5. Stripp, B.: Intestinal absorption of riboflavin by man. Acta Pharmacol. Toxicol., 22: 353-362 (1965).
6. Gramatte, T.: Griseofulvin absorption from diŝerent sites in the human small intestine. Biopharm. Drug Dispos., 15: 747-759 (1994).
7. Kimura, T. and Higaki, K.: Gastrointestinal transit and drug absorption. Biol. Pharm. Bull., 25: 149-164 (2002).
8. Mayerson, M.: Principles of drug absorption, In G. S. Banker and C. T. Rhodes (ed.), Modern Pharmaceutics, 3rd ed., Marcel Dekker, New York, 1996, pp. 21-71.
9. Wacher, V. J., Salphati, L. and Benet, L. Z.: Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Deliv. Rev., 20: 157-180 (1996).
10. Sawamoto, T., Haruta, S., Kurosaki, Y., Higaki, K. and Kimura, T.: Prediction of the plasma concentration prô-les of orally administered drugs in rats on the basis of gastrointestinal transit kinetics and absorbability. J. Pharm. Pharmacol., 49: 450-457 (1997).
11. Kimura, T., Iwasaki, N., Yokoe, J., Haruta, S., Yokoo, Y., Ogawara, K. and Higaki, K.: Analysis and prediction of absorption prôle including hepatiĉrst-pass metabolism of N-methyltyramine, a potent stimulant of gastrin release present in beer, afer oral ingestion in rats by gastrointestinal-transit-absorption model. Drug Metab. Dispos., 28: 577-581 (2000).
12. Haruta, S., Kawai, K., Jinnouchi, S., Ogawara, K., Higaki, K., Tamura, S., Arimori, K. and Kimura, T.: Evaluation of absorption kinetics of orally administered theophylline in rats based on gastrointestinal transit monitoring by gamma scintigraphy. J. Pharm. Sci., 90: 464-473 (2001).
13. Haruta, S., Kawai, K., Nishii, R., Jinnouchi, S., Ogawara, K., Higaki, K., Tamura, S., Arimori, K. and Kimura, T.: Prediction of plasma concentration-time curve of orally administered theophylline based on a scintigraphic monitoring of gastrointestinal transit in human volunteers. Int. J. Pharm., 233: 179-190 (2002).
14. Yokoe, J., Iwasaki, N., Haruta, S., Kadono, K., Ogawara, K., Higaki, K. and Kimura, T.: Simultaneous prediction of absorption kinetics for 5-aminosalycilic acid and its colon-targeted prodrug, salicylazosulfanilic acid, by gastrointestinal-transit-absorption model submitted.
15. Amidon, G. L., Lennernas, H., Shah, V. P. and Crison, J. R.: A theoretical basis for a biopharmaceutic drug classîcation: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res., 12: 413-420 (1995).
16. Yano, Y., Yamaoka, K. and Tanaka, H.: A nonlinear least squares program. MULTI (FILT), based on fast inverse Laplace transform for microcomputer. Chem. Pharm. Bull., 37: 1035-1038 (1989).
17. Yamaoka, K. and Tanigawara, Y.: Deconvolution. Introduction to Pharmacokinetic Analysis by Microcomputer, Tokyo, Nankodo, 1984, pp. 91-112.
18. Hinder, R. A. and Kelly, K. A.: Canine gastric emptying of solids and liquids. Am. J. Physiol., 233: E335-E340 (1977).
19. Camilleri, M., Malagelada, J. R., Brown, M. L. and Becker, G.: Relation between antral motility and gastric emptying of solids and liquids in humans. Am. J. Physiol., 249: G580-G585 (1985).
20. Davis, S. S., Stockwell, A. F., Taylor, M. J., Hardy, J. G., Shalley, D. R., Wilson, C. G., Bechgaard, H. and Christensen, F. N.: The eŝect of density on the gastric emptying of single-and multiple-unit dosage forms Pharm. Res., 3: 208-213 (1986).
21. Devereux, J. E., Newton, J. M. Short, M. B.: The influence of density on the gastrointestinal transit of pellets. J. Pharm. Pharmacol., 42: 500-501 (1990).
22. Tuleu, C., Andrieux, C., Boy, P. and Chaumeil, J. C.: Gastrointestinal transit of pellets in rats: eŝect of size and density. Int. J. Pharm., 180: 123-131 (1999).
23. Martin, A. Micromeritics. In Physical Pharmacy. Baltimore, Williams & Wilkins, 1993, pp. 423-452.
24. Davis, S. S., Hardy, J. G. and Fara, J. W.: Transit of pharmaceutical dosage forms through the small intestine. Gut, 27: 886-892 (1986).
25. Abrahamsson, B., Alpsten, M., Hugosson, M., Jonsson, U. L. F. E., Sundgren M., Svenheden, A. and Toälli, J.: Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets. Pharm. Res., 10: 709-714 (1993).
26. Peh, K. K. and Yuen, K. H.: Indirect gastrointestinal transit monitoring and absorption of theophylline. Int. J. Pharm., 139: 95-103 (1996).
27. Tanigawara, Y., Yamaoka, K., Nakagawa, T. and Uno, T.: New method for the evaluation of in vitro dissolution time and disintegration time. Chem. Pharm. Bull., 30: 1088-1090 (1982).
28. Tanigawara, Y., Yamaoka, K., Nakagawa, T. and Uno, T.: Correlation between in vivo mean dissolution time and in vitro mean dissolution time of ampicillin products. J. Pharmacobio-Dyn., 5: 370-372 (1982).
29. Levy, G., Leeonards, J. R. and Prockual, J. A.: Development of in vitro dissolution tests which correlate quantitatively with dissolution rate-limited drug absorption in man. J. Pharm. Sci., 54: 1719-1722 (1965).
30. Gibaldi, M. and Feldman, S.: Establishment of sink conditions in dissolution rate determinations: Theoretical considerations and application to nondisintegrating dosage forms. J. Pharm. Sci., 56: 1238-1242 (1967).